About
3.45USD-0.12 -3.36%
Closed • Updated at 22:21 GMT+00:00Market Cap$358.40M
Volume1.13M
Beta1.27
RSI34.95
Larimar Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 30 2026
Larimar Therapeutics Publishes Cross-Species Findings Supporting Skin as a Surrogate for the Measurement of Frataxin in Tissues Clinically Relevant to Friedreich’s Ataxia
Mar 19 2026
Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 4 2026
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
Feb 25 2026
Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering
Feb 25 2026
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering
Community Chat
Ask AI
Try asking
Translate